New England-Based Case-Control Study of Ovarian Cancer (NECC)

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

C. Pearce, C. Templeman, M. Rossing, et al.. (2012). The Lancet. Oncology. Cited 840 times. https://doi.org/10.1016/S1470-2045(11)70404-1

Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.

R. Ness, D. Cramer, M. Goodman, et al.. (2002). American journal of epidemiology. Cited 429 times. https://doi.org/10.1093/AJE/155.3.217

Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.

R. Ness, D. Cramer, M. Goodman, et al.. (2002). American journal of epidemiology. Cited 429 times. https://doi.org/10.1093/AJE/155.3.217

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

Honglin Song, S. Ramus, J. Tyrer, et al.. (2009). Nature Genetics. Cited 316 times. https://doi.org/10.1038/ng.424

Common variants at 19p13 are associated with susceptibility to ovarian cancer

K. Bolton, J. Tyrer, Honglin Song, et al.. (2010). Nature genetics. Cited 267 times. https://doi.org/10.1038/ng.666

Over-the-counter analgesics and risk of ovarian cancer

Daniel W. Cramer, Bernard L. Harlow, L. Titus-Ernstoff, et al.. (1998). The Lancet. Cited 218 times. https://doi.org/10.1016/S0140-6736(97)08064-1

Over-the-counter analgesics and risk of ovarian cancer

Daniel W. Cramer, Bernard L. Harlow, L. Titus-Ernstoff, et al.. (1998). The Lancet. Cited 218 times. https://doi.org/10.1016/S0140-6736(97)08064-1

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

B. Trabert, R. Ness, W. Lo‐Ciganic, et al.. (2014). Journal of the National Cancer Institute. Cited 215 times. https://doi.org/10.1093/jnci/djt431

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.

C. Olsen, C. Nagle, D. Whiteman, et al.. (2013). Endocrine-related cancer. Cited 204 times. https://doi.org/10.1530/ERC-12-0395

Menstrual and reproductive factors in relation to ovarian cancer risk

L. Titus-Ernstoff, K. Perez, D. Cramer, et al.. (2001). British Journal of Cancer. Cited 203 times. https://doi.org/10.1054/bjoc.2000.1596

Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.

K. Williams, K. Williams, S. Labidi-Galy, et al.. (2014). Gynecologic oncology. Cited 175 times. https://doi.org/10.1016/j.ygyno.2014.01.026

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Hui Shen, B. Fridley, Honglin Song, et al.. (2013). Nature Communications. Cited 173 times. https://doi.org/10.1038/ncomms2629

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

W. Sieh, S. Salvador, V. McGuire, et al.. (2013). International journal of epidemiology. Cited 170 times. https://doi.org/10.1093/ije/dyt042

Conditions Associated with Antibodies Against the Tumor-Associated Antigen MUC1 and Their Relationship to Risk for Ovarian Cancer

D. Cramer, L. Titus-Ernstoff, J. McKolanis, et al.. (2005). Cancer Epidemiology Biomarkers & Prevention. Cited 134 times. https://doi.org/10.1158/1055-9965.EPI-05-0035

Carotenoids, antioxidants and ovarian cancer risk in pre‐ and postmenopausal women

D. Cramer, H. Kuper, B. Harlow, et al.. (2001). International Journal of Cancer. Cited 123 times. https://doi.org/10.1002/ijc.1435

Carotenoids, antioxidants and ovarian cancer risk in pre‐ and postmenopausal women

D. Cramer, H. Kuper, B. Harlow, et al.. (2001). International Journal of Cancer. Cited 123 times. https://doi.org/10.1002/ijc.1435

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Melissa A Merritt, Melissa A Merritt, M. D. Pari, et al.. (2013). Human reproduction. Cited 112 times. https://doi.org/10.1093/humrep/des466

Flavonoid intake and ovarian cancer risk in a population‐based case‐control study

Margaret A. Gates, A. Vitonis, S. Tworoger, et al.. (2009). International Journal of Cancer. Cited 105 times. https://doi.org/10.1002/ijc.24151

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies

M. T. Faber, S. Kjær, C. Dehlendorff, et al.. (2013). Cancer Causes & Control. Cited 105 times. https://doi.org/10.1007/s10552-013-0174-4

Genital talc exposure and risk of ovarian cancer

D. Cramer, R. Liberman, L. Titus-Ernstoff, et al.. (1999). International Journal of Cancer. Cited 104 times. https://doi.org/10.1002/(SICI)1097-0215(19990505)81:3<351::AID-IJC7>3.0.CO;2-M

Genital talc exposure and risk of ovarian cancer

D. Cramer, R. Liberman, L. Titus-Ernstoff, et al.. (1999). International Journal of Cancer. Cited 104 times. https://doi.org/10.1002/(SICI)1097-0215(19990505)81:3<351::AID-IJC7>3.0.CO;2-M

ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study

J. Doherty, M. Rossing, K. Cushing-Haugen, et al.. (2010). Cancer Epidemiology, Biomarkers & Prevention. Cited 98 times. https://doi.org/10.1158/1055-9965.EPI-09-0729

Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls

K. Terry, S. Karageorgi, Yurii B. Shvetsov, et al.. (2013). Cancer Prevention Research. Cited 90 times. https://doi.org/10.1158/1940-6207.CAPR-13-0037

LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.

Jennifer Permuth‐Wey, Donghwa Kim, Ya‐Yu Tsai, et al.. (2011). Cancer research. Cited 83 times. https://doi.org/10.1158/0008-5472.CAN-10-4167

Epidemiologic perspective on immune-surveillance in cancer.

D. Cramer, O. Finn. (2011). Current opinion in immunology. Cited 82 times. https://doi.org/10.1016/j.coi.2011.01.002

Genetic variation in the progesterone receptor gene and ovarian cancer risk.

K. Terry, I. De Vivo, L. Titus-Ernstoff, et al.. (2005). American journal of epidemiology. Cited 79 times. https://doi.org/10.1093/AJE/KWI064

Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.

J. Schildkraut, E. Goode, M. Clyde, et al.. (2009). Cancer research. Cited 77 times. https://doi.org/10.1158/0008-5472.CAN-08-2902

Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.

Margarita Aponte, Wei Jiang, M. Lakkis, et al.. (2008). Cancer research. Cited 76 times. https://doi.org/10.1158/0008-5472.CAN-07-5771

Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence.

B. Ye, Margarita Aponte, Yan Dai, et al.. (2007). Cancer letters. Cited 76 times. https://doi.org/10.1016/J.CANLET.2006.10.025

Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?

H. Kuper, D. Cramer, L. Titus-Ernstoff. (2002). Cancer Causes & Control. Cited 72 times. https://doi.org/10.1023/A:1015751105039

Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?

H. Kuper, D. Cramer, L. Titus-Ernstoff. (2002). Cancer Causes & Control. Cited 72 times. https://doi.org/10.1023/A:1015751105039

Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian Cancer

K. Terry, L. Titus-Ernstoff, J. McKolanis, et al.. (2007). Cancer Epidemiology Biomarkers & Prevention. Cited 72 times. https://doi.org/10.1158/1055-9965.EPI-06-0688

Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”

S. Johnatty, J. Beesley, Xiaoqing Chen, et al.. (2010). PLoS Genetics. Cited 69 times. https://doi.org/10.1371/journal.pgen.1001016

Multiple births and risk of epithelial ovarian cancer.

D. Whiteman, M. Murphy, L. Cook, et al.. (2000). Journal of the National Cancer Institute. Cited 68 times. https://doi.org/10.1093/JNCI/92.14.1172

Hormonal and Reproductive Risk Factors for Epithelial Ovarian Cancer by Tumor Aggressiveness

E. Poole, M. Merritt, S. Jordan, et al.. (2013). Cancer Epidemiology, Biomarkers & Prevention. Cited 65 times. https://doi.org/10.1158/1055-9965.EPI-12-1183-T

Psychotropic medication use and risk of epithelial ovarian cancer.

Bernard L. Harlow, Daniel W. Cramer, John A. Baron, et al.. (1998). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 62 times.

Psychotropic medication use and risk of epithelial ovarian cancer.

A case-control study of galactose consumption and metabolism in relation to ovarian cancer.

D. Cramer, E. Greenberg, L. Titus-Ernstoff, et al.. (2000). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 61 times.

A case-control study of galactose consumption and metabolism in relation to ovarian cancer.

The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing

P. Pharoah, Rachel T. Palmieri, S. Ramus, et al.. (2011). Clinical Cancer Research. Cited 60 times. https://doi.org/10.1158/1078-0432.CCR-10-3405

Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy

A. Vitonis, L. Titus-Ernstoff, D. Cramer. (2011). Obstetrics & Gynecology. Cited 60 times. https://doi.org/10.1097/AOG.0b013e318212fcb7

Talc Use, Variants of the GSTM1, GSTT1, and NAT2 Genes, and Risk of Epithelial Ovarian Cancer

Margaret A. Gates, S. Tworoger, K. Terry, et al.. (2008). Cancer Epidemiology Biomarkers & Prevention. Cited 60 times. https://doi.org/10.1158/1055-9965.EPI-08-0399

Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case–Control Study

M. Rice, M. A. Murphy, A. Vitonis, et al.. (2013). International Journal of Cancer. Cited 57 times. https://doi.org/10.1002/ijc.28249

Folate, vitamin B6, vitamin B12, methionine and alcohol intake in relation to ovarian cancer risk

H. Harris, D. Cramer, A. Vitonis, et al.. (2012). International Journal of Cancer. Cited 53 times. https://doi.org/10.1002/ijc.26455

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

Bridget Charbonneau, M. Block, W. Bamlet, et al.. (2014). Cancer research. Cited 48 times. https://doi.org/10.1158/0008-5472.CAN-13-1051

Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.

K. Terry, S. Tworoger, Margaret A. Gates, et al.. (2009). Carcinogenesis. Cited 44 times. https://doi.org/10.1093/carcin/bgp257

Telomere Length and Genetic Variation in Telomere Maintenance Genes in Relation to Ovarian Cancer Risk

K. Terry, S. Tworoger, A. Vitonis, et al.. (2012). Cancer Epidemiology, Biomarkers & Prevention. Cited 41 times. https://doi.org/10.1158/1055-9965.EPI-11-0867

MTHFR polymorphisms in relation to ovarian cancer risk.

K. Terry, S. Tworoger, E. Goode, et al.. (2010). Gynecologic oncology. Cited 40 times. https://doi.org/10.1016/j.ygyno.2010.08.007

ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium

E. Poole, Margaret A. Gates, Brigit High, et al.. (2012). Cancer Causes & Control. Cited 39 times. https://doi.org/10.1007/s10552-012-0059-y

Dietary fat intake and risk of epithelial ovarian cancer by tumour histology

Melissa A Merritt, Melissa A Merritt, Melissa A Merritt, et al.. (2014). British Journal of Cancer. Cited 38 times. https://doi.org/10.1038/bjc.2014.16

Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium

L. Kelemen, E. Bandera, K. Terry, et al.. (2013). BMC Cancer. Cited 37 times. https://doi.org/10.1186/1471-2407-13-28

CA125 immune complexes in ovarian cancer patients with low CA125 concentrations.

D. Cramer, Dennis O'Rourke, A. Vitonis, et al.. (2010). Clinical chemistry. Cited 36 times. https://doi.org/10.1373/clinchem.2010.153122

Correlates of the preoperative level of CA125 at presentation of ovarian cancer.

D. Cramer, A. Vitonis, W. Welch, et al.. (2010). Gynecologic oncology. Cited 35 times. https://doi.org/10.1016/j.ygyno.2010.08.028

Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk

G. Lurie, K. Terry, L. Wilkens, et al.. (2010). Cancer Causes & Control. Cited 32 times. https://doi.org/10.1007/s10552-010-9602-x

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival

K. Williams, K. Terry, S. Tworoger, et al.. (2014). PLoS ONE. Cited 31 times. https://doi.org/10.1371/journal.pone.0088334

Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes

M. Merritt, D. Cramer, A. Vitonis, et al.. (2013). International Journal of Cancer. Cited 31 times. https://doi.org/10.1002/ijc.27701

Breast-feeding the last born child and risk of ovarian cancer

L. Titus-Ernstoff, J. Rees, K. Terry, et al.. (2010). Cancer Causes & Control. Cited 29 times. https://doi.org/10.1007/s10552-009-9450-8

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

M. Earp, L. Kelemen, A. Magliocco, et al.. (2013). Human Genetics. Cited 26 times. https://doi.org/10.1007/s00439-013-1383-3

Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.

A. Near, A. Wu, C. Templeman, et al.. (2011). Fertility and sterility. Cited 26 times. https://doi.org/10.1016/j.fertnstert.2010.06.059

Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.

C. Phelan, Ya‐Yu Tsai, E. Goode, et al.. (2010). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 25 times. https://doi.org/10.1158/1055-9965.EPI-09-0861

Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium

Lifang Zhang, Dan Wang, Wei Jiang, et al.. (2010). Reproductive Biology and Endocrinology : RB&E. Cited 24 times. https://doi.org/10.1186/1477-7827-8-74

Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

Bridget Charbonneau, K. Moysich, K. Kalli, et al.. (2014). Cancer Immunology Research. Cited 23 times. https://doi.org/10.1158/2326-6066.CIR-13-0136

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)

F. Modugno, R. Moslehi, R. Ness, et al.. (2003). Cancer Causes & Control. Cited 22 times. https://doi.org/10.1023/A:1024932427503

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

Alice W. Lee, J. Tyrer, J. Doherty, et al.. (2015). Gynecologic oncology. Cited 21 times. https://doi.org/10.1016/j.ygyno.2014.12.017

MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium

Jennifer Permuth‐Wey, Zhihua Chen, Ya‐Yu Tsai, et al.. (2011). Cancer Epidemiology, Biomarkers & Prevention. Cited 20 times. https://doi.org/10.1158/1055-9965.EPI-11-0397

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

A. Hollestelle, Frederieke H van der Baan, A. Berchuck, et al.. (2016). Gynecologic oncology. Cited 20 times. https://doi.org/10.1016/j.ygyno.2015.04.034

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

A. Hollestelle, Frederieke H van der Baan, A. Berchuck, et al.. (2016). Gynecologic oncology. Cited 20 times. https://doi.org/10.1016/j.ygyno.2015.04.034

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium

C. Pearce, A. Near, D. J. Van Den Berg, et al.. (2009). British Journal of Cancer. Cited 19 times. https://doi.org/10.1038/sj.bjc.6604820

Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin

J. Kotsopoulos, K. Terry, E. Poole, et al.. (2013). International Journal of Cancer. Cited 19 times. https://doi.org/10.1002/ijc.28064

Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider

H. Abenhaim, L. Titus-Ernstoff, D. Cramer. (2007). Canadian Medical Association Journal. Cited 13 times. https://doi.org/10.1503/cmaj.060697

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

L. Kelemen, K. Terry, M. Goodman, et al.. (2014). Molecular nutrition & food research. Cited 12 times. https://doi.org/10.1002/mnfr.201400068

Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

M. Block, Bridget Charbonneau, R. Vierkant, et al.. (2014). Cancer Epidemiology, Biomarkers & Prevention. Cited 11 times. https://doi.org/10.1158/1055-9965.EPI-13-0962

Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk

D. Cramer, K. Williams, A. Vitonis, et al.. (2013). Cancer Causes & Control. Cited 10 times. https://doi.org/10.1007/s10552-013-0266-1

Menstrual pain and epithelial ovarian cancer risk

A. Babic, D. Cramer, L. Titus, et al.. (2014). Cancer Causes & Control. Cited 10 times. https://doi.org/10.1007/s10552-014-0463-6

Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations

Margaret A. Gates, S. Tworoger, K. Terry, et al.. (2009). International Journal of Cancer. Cited 9 times. https://doi.org/10.1002/ijc.23924

A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies.

K. Terry, A. Vitonis, D. Hernandez, et al.. (2010). International journal of molecular epidemiology and genetics. Cited 6 times.

Genetic variation in telomere maintenance genes in relation to ovarian cancer survival.

H. Harris, I. Vivo, L. Titus, et al.. (2012). International journal of molecular epidemiology and genetics. Cited 5 times.

Prostate Cancer Susceptibility Polymorphism rs2660753 Is Not Associated with Invasive Ovarian Cancer

E. Amankwah, L. Kelemen, Qinggang Wang, et al.. (2011). Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.EPI-11-0053

Duarte galactose-1-phosphate uridyl transferase genotypes are not associated with ovarian cancer risk.

M. Merritt, J. Kotsopoulos, D. Cramer, et al.. (2012). Fertility and sterility. https://doi.org/10.1016/j.fertnstert.2012.05.045

Non-Genomic Biomarkers of Risk in Ovarian Cancer

Simone P. Pinheiro, D. Cramer. (2007). Disease markers. https://doi.org/10.1155/2007/864803